Literature DB >> 22918779

Personalized image-based radiation dosimetry for routine clinical use in peptide receptor radionuclide therapy: pretherapy experience.

Anna Celler1, Joshua Grimes, Sergey Shcherbinin, Hanna Piwowarska-Bilska, Bozena Birkenfeld.   

Abstract

Patient-specific dose calculations are not routinely performed for targeted radionuclide therapy procedures, partly because they are time consuming and challenging to perform. However, it is becoming widely recognized that a personalized dosimetry approach can help plan treatment and improve understanding of the dose-response relationship. In this chapter, we review the procedures and essential elements of an accurate internal dose calculation and propose a simplified approach that is aimed to be practical for use in a busy nuclear medicine department.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 22918779     DOI: 10.1007/978-3-642-27994-2_29

Source DB:  PubMed          Journal:  Recent Results Cancer Res        ISSN: 0080-0015


  3 in total

1.  Technical Note: Simplified and practical pretherapy tumor dosimetry - A feasibility study for 131 I-MIBG therapy of neuroblastoma using 124 I-MIBG PET/CT.

Authors:  Youngho Seo; Yoonsuk Huh; Shih-Ying Huang; J Miguel Hernandez-Pampaloni; Randall A Hawkins; W Clay Gustafson; Kieuhoa T Vo; Katherine K Matthay
Journal:  Med Phys       Date:  2019-03-12       Impact factor: 4.071

2.  Technical Note: Single time point dose estimate for exponential clearance.

Authors:  Mark T Madsen; Yusuf Menda; Thomas M O'Dorisio; M Sue O'Dorisio
Journal:  Med Phys       Date:  2018-04-16       Impact factor: 4.071

3.  Application of machine learning to pretherapeutically estimate dosimetry in men with advanced prostate cancer treated with 177Lu-PSMA I&T therapy.

Authors:  Song Xue; Andrei Gafita; Chao Dong; Yu Zhao; Giles Tetteh; Bjoern H Menze; Sibylle Ziegler; Wolfgang Weber; Ali Afshar-Oromieh; Axel Rominger; Matthias Eiber; Kuangyu Shi
Journal:  Eur J Nucl Med Mol Imaging       Date:  2022-06-30       Impact factor: 10.057

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.